• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / Media / About / SANE Vax Press Releases / SaneVax Writes Open Letter to Kathleen Sebelius, Secretary of Health: Rescind approval of Gardasil® due to lack of efficacy during post-licensure monitoring

SaneVax Writes Open Letter to Kathleen Sebelius, Secretary of Health: Rescind approval of Gardasil® due to lack of efficacy during post-licensure monitoring

February 2, 2012 By admin 7 Comments

 

 

 

By Norma Erickson, President.

According to a recently published, industry-sponsored study conducted on 12,852 young women, HPV vaccination was found to reduce HPV-16 infections a mere 0.6% in vaccinated women versus unvaccinated women. At the same time, other high-risk (carcinogenic) HPV infections were diagnosed in vaccinated women 2.6% to 6.2% more frequently than in the unvaccinated women. The increased rate of infections caused by carcinogenic HPV types other than those targeted by Gardasil® in vaccinated women is 4 to 10 times higher than the reduction in HPV 16/18 infections.[1]

These statistics are not exactly encouraging when it comes to demonstrating efficacy for Gardasil®. In fact, quite the opposite – these figures seem to indicate that women who receive Gardasil® may indeed increase their risk of developing cervical cancer from high-risk HPV types that are not targeted by the vaccine.

Medical consumers cannot afford to take the chance of increasing their risk of contracting a disease that has been virtually eradicated by good gynecological care in the United States (cervical cancer) by taking a series of HPV vaccines and hoping they will find out decades later the vaccine worked. It is certainly not a risk children should have to take.

Armed with the knowledge that any drug approved under the FDA’s accelerated approval process using a surrogate endpoint, such as Gardasil®, requires post-marketing studies “to verify and describe the drugs clinical benefit and to resolve remaining uncertainty as to the relation of the surrogate endpoint upon which approval was based to clinical benefit…[2],” the SaneVax Team felt compelled to appeal to the person in charge of FDA/CDC oversight, Kathleen Sebelius, Secretary of Health and Human Services.

On 31 January 2012, SaneVax Inc. sent an open letter to Ms Sebelius[3] asking her to rescind approval for Gardasil® based on the lack of efficacy demonstrated in the ATHENA study referenced above.

If the Department of Health and Human Services is truly interested in public health and safety, they will do the right thing and rescind Gardasil® approval until the manufacturer can provide scientifically sound data proving this new drug is actually effective.

In the meantime, medical consumers around the globe have a choice. Is poke and hope good enough for you and your children? Or, are you going to demand scientific proof of efficacy before submitting to HPV vaccination?



[1] http://www.ncbi.nlm.nih.gov/pubmed/21944226 (see table 3, The ATHENA human papillomavirus study: design, methods, and baseline results.)

[2] http://www.fda.gov/ohrms/dockets/ac/03/briefing/3936B1_01_B-Attachment%201.pdf (57 FR 58942)

[3] Copy of letter to Kathleen Sebelius, Secretary of Health and Human Services

Related

Filed Under: SANE Vax Press Releases Tagged With: FDA approval, Gardasil, HHS, Kathleen Sebelius, lack of efficacy, rescind approval

Comments

  1. Mindanoiha says

    February 6, 2012 at 12:38 pm

    The letter from the SaneVax team to Kathleen Sebelius, Secretary of Health and Human Services is an excellent initiative.

    In addition to the tragic numbers of adverse events and deaths related to Gardasil, irregularities in connection with clinical trials, marketing and reporting of adverse events and the discovery of potentially dangerous HPV DNA, there is now information demonstrating lack of efficacy and increased risk of cervical cancer.

    The objective of the ATHENA study was to describe baseline data from addressing the need for advanced HPV diagnostics. Information in the study also demonstrates lack of efficacy and increased risk of cervical cancer in the vaccinated subjects.

    ATHENA study, Table 3: http://www.scribd.com/fullscreen/80272698

    The SaneVax team have rightly requested that Gardasil approval be rescinded. This vaccine should never have been approved.

    Reply

Trackbacks

  1. SaneVax Inc Writes Open Letter to Kathleen Sebelius, Secretary of Health and Human Services: Rescind Gardasil Approval says:
    February 2, 2012 at 6:11 am

    […] SANE Vax Inc. https://sanevax.org/sanevax-writes-open-letter-to-kathleen-sebelius-secretary-of-health-rescind-appro… Filed Under: Gardasil/Silgard, Inconvenient Woman, SANE VAX Inc., SANE VAX Inc. Press Releases, […]

    Reply
  2. SaneVax Writes Open Letter to Kathleen Sebelius, Secretary of Health: Rescind approval of Gardasil® due to lack of efficacy during post-licensure monitoring | Philosophers stone says:
    February 2, 2012 at 10:40 am

    […] [Source…] […]

    Reply
  3. The Robert Scott Bell Show a Happy 1st Anniversary! Natural News Radio, Mike Adams, Bill Gates Merck Eugenics, Zapping Birth Control Equality, FDA Human Stem Cell Drug Declaration, Liam Scheff, AAP Gardasil Mandates for Boys, Real Birth Defect Prevention says:
    February 2, 2012 at 4:18 pm

    […] SaneVax open letter to Kathleen Sebelius at the Department of Health and Human Services – withdraw Gardasil now! https://sanevax.org/sanevax-writes-open-letter-to-kathleen-sebelius-secretary-of-health-rescind-appro… […]

    Reply
  4. SANEVax Calls Out Secretary Of Health To Rescind Approval Of Gardasil HPV Vaccine says:
    February 3, 2012 at 6:15 pm

    […] Source: SaneVax.org […]

    Reply
  5. Society for Menstrual Cycle Research : » Vaginas, Labia, If Men Had Periods, and More Weekend Links says:
    February 4, 2012 at 1:01 pm

    […] SaneVax asks Kathleen Sebelius (Secretary of Health and Human Services) to rescind approval of Garda…. […]

    Reply
  6. Vaginas, Labia, If Men Had Periods, and More Weekend Links – Dr. Kissling says:
    September 18, 2019 at 12:31 am

    […] SaneVax asks Kathleen Sebelius (Secretary of Health and Human Services) to rescind approval of Garda…. […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

I Survived Cervarix

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

Leigh O’Dell on Gardasil

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...